Trajan for Grace Davisil Silica and Chem Service Standards in Australia and New Zealand

Trajan for Grace Davisil Silica and Chem Service Standards in Australia and New Zealand

May 01, 2016

Trajan Scientific and Medical (Trajan), together with Grace Discovery Sciences (Grace) are delighted to advise that from 1 May 2016, Trajan is the new point of contact for the Grace Davisil Silica business in Australia and New Zealand. Additionally Trajan have taken on representation for the Chem Service Analytical Standards range previously handled by Grace.

Ms Kellie Neagle (Grace Customer Service) will be continuing her role, joining the Trajan team supporting these products. Grace has a history of providing exceptional customer service and quality products, and with Trajan as a customer-oriented business we are confident that all of our customers will continue to receive support and technical expertise through Kellie and the Trajan Australia and New Zealand Team.

Also recently joining Trajan is Mr Tony Anissa (Chromatography Business Development Manager, Australia and New Zealand). Tony is a chromatography specialist, who has previously worked at Grace and is familiar with the SGE, Chem Service and Davisil product portfolios.

Trajan supplies innovative products to support work in the laboratory.

Australia and New Zealand
anz@trajanscimed.com

Media contact information
media@trajanscimed.com
+44 (0) 1244 403 100




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More